Article info
Review
Semaglutide: a new drug for the treatment of obesity
- Correspondence to Professor Joel Lexchin, School of Health Policy and Management, York University - Keele Campus, Toronto, ON M3J 1P3, Canada; jlexchin{at}yorku.ca
Citation
Semaglutide: a new drug for the treatment of obesity
Publication history
- First published October 25, 2023.
Online issue publication
November 29, 2023
Article Versions
- Previous version (29 November 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.